EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Novel Genetic Risk Factor Identified for L‐Asparaginase‐Induced Pancreatitis in Pediatric Patients With Cancer

Edward J Raack, Wan-Chun Chang iD, Miguel Cordova-Delgado iD, Spencer J Anderson, Jessica N Trueman, Erika N Scott, Catrina M Loucks, Shahrad R Rassekh, Gabriella S S Groeneweg, Michelle Higginson, Kathy Li, Fudan Miao und 28 weitere

Pediatric Blood & Cancer · 2026-06 · 73 (6)

DOI: 10.1002/1545-5017.70284 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 26.03.2026. Verfasst von Edward J Raack und 39 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Asparaginase, Pancreatitis, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CIHR, Genome Canada, Genome British Columbia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

L‐asparaginase is a critical component in treatment protocols for pediatric acute lymphoblastic leukemia. Acute pancreatitis reactions can necessitate delays and, in some cases, discontinuation of L‐asparaginase, which compromises outcomes. Procedure Genome‐wide analyses were conducted to identify significant associations between single‐nucleotide polymorphisms and risk for L‐asparaginase‐induced pancreatitis in 1086 pediatric patients treated on acute lymphoblastic leukemia treatment protocols. Patients were randomly split 75/25 into independent Discovery ( n = 824) and Replication ( n = 262) cohorts. Cases experienced Common Terminology Criteria for Adverse Events v5.0 Grades 3–4 acute pancreatitis reactions due to L‐asparaginase treatment. Controls received L‐asparaginase but did not develop acute pancreatitis.

Results

A significant association was observed between the rs149210846 variant and L‐asparaginase‐induced pancreatitis (odds ratio [OR] = 8.9; 95% confidence interval [CI]: 3.6–22.3; p = 1.8 × 10 −8 ) and was confirmed in the replication analysis (OR = 6.2; 95% CI: 1.1–35.0; p = 0.02). Carriers had 5.9‐fold (95% CI: 1.9–16.3; p = 0.002) and 7.7‐fold (95% CI: 1.3–29.3; p = 0.01) increased risk of severe Grade 3 and Grade 4 acute pancreatitis reactions, respectively, relative to non‐carriers. Moreover, patients of Admixed‐American (OR = 8.8; 95% CI: 2.4–34.6; p = 1.45 × 10 −3 ) and Asian (OR = 10.0; 95% CI: 1.9–53.6; p = 8.06 × 10 −3 ) genetic ancestries were at significantly higher risk.

Conclusions

These findings will allow clinicians to proactively conduct stricter monitoring of patients at higher risk for L‐asparaginase‐induced pancreatitis and inform future development of protective agents that can be used concomitantly to mitigate their risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsparaginasePancreatitisPrecursor Cell Lymphoblastic Leukemia-LymphomaPolymorphism, Single NucleotideGenetic Predisposition to DiseaseAntineoplastic AgentsHumansFemaleChildMaleRisk FactorsChild, PreschoolAdolescentInfantGenome-Wide Association StudyPrognosisFollow-Up Studies

Stichwörter der Autor:innen

L‐asparaginaseacute lymphoblastic leukemiapancreatitispediatricspharmacogenomics

Substanzen

AsparaginaseAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • British Columbia Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
  • Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada.
  • Department of Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Division of Hematology, Oncology & Bone Marrow Transplant, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

ORCID-Profile: Wan-Chun Chang, Miguel Cordova-Delgado, Maja Krajinovic, Zara Forbrigger, Bruce C Carleton

Förderung

  • CIHR
  • Genome Canada
  • Genome British Columbia
  • Provincial Health Services Authority
  • BC Children's Hospital Foundation
  • Health Canada
  • Canadian Institutes of Health Research

Zitieren

APA

Raack, E. J., Chang, W. C., Cordova-Delgado, M., Anderson, S. J., Trueman, J. N., Scott, E. N., Loucks, C. M., Rassekh, S. R., Groeneweg, G. S. S., Higginson, M., Li, K., Miao, F., Yau, D., Johnston, D., Ibrahim, M., Krajinovic, M., Tran, T. H., Tewfik, J., Bussières, J. F., …, & Carleton, B. C. (2026). Novel Genetic Risk Factor Identified for L‐Asparaginase‐Induced Pancreatitis in Pediatric Patients With Cancer. Pediatric Blood & Cancer, 73(6). https://doi.org/10.1002/1545-5017.70284

Vancouver

Raack EJ, Chang WC, Cordova-Delgado M, Anderson SJ, Trueman JN, Scott EN, et al. Novel Genetic Risk Factor Identified for L‐Asparaginase‐Induced Pancreatitis in Pediatric Patients With Cancer. Pediatric Blood & Cancer. 2026;73(6). doi:10.1002/1545-5017.70284

BibTeX
@article{Raack2026,
  author = {Raack, Edward J and Chang, Wan-Chun and Cordova-Delgado, Miguel and Anderson, Spencer J and Trueman, Jessica N and Scott, Erika N and Loucks, Catrina M and Rassekh, Shahrad R and Groeneweg, Gabriella S S and Higginson, Michelle and Li, Kathy and Miao, Fudan and Yau, Derek and Johnston, Donna and Ibrahim, Mounira and Krajinovic, Maja and Tran, Thai Hoa and Tewfik, Jessica and Bussières, Jean-François and Jean-Baptiste, Thaïna-Rafi and Lebel, Denis and Pecheux, Lucie and Gyawali, Bina and Guilcher, Gregory and Riabowol, Gesche and Jong, Geert 't and Staub, Michelle and Cuvelier, Geoff and Felton, Kathleen and Khalaj, Sara and Rieder, Michael and Abuzgaia, Awatif and Lewis, Tamorah and Ghimire, Himal and Nathan, Paul and Goralski, Kerry and Kulkarni, Ketan and Forbrigger, Zara and Ross, Colin J D and Carleton, Bruce C},
  title = {Novel Genetic Risk Factor Identified for L‐Asparaginase‐Induced Pancreatitis in Pediatric Patients With Cancer},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  volume = {73},
  number = {6},
  doi = {10.1002/1545-5017.70284}
}
Kostenlos starten →